BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Concentrations (Tables)

Concentrations (Tables)

3 Months Ended

Mar. 31, 2020

Risks And Uncertainties [Abstract]

Schedule of Revenue and Percentages of Revenue Sales by Product Line

The revenue and percentages of revenue of the Company’s sales by product line were as follows for the periods indicated:

		Three Months Ended
		March 31,
		2020								2019
Laser systems		$	2,051				42.9	%		$	5,964				57.8	%
Imaging systems			—				—	%			552				5.3	%
Consumables and other			1,472				30.8	%			2,112				20.5	%
Services			1,260				26.3	%			1,695				16.4	%
License fees and royalties			—				—	%			3				—	%
Total revenue		$	4,783				100.0	%		$	10,326				100.0	%

Revenue from the Company’s products for the three months ended March 31, 2020 and 2019 are as follows (dollars in thousands):

		Three Months Ended
		March 31,
		2020								2019
Laser systems		$	2,051				42.9	%		$	5,964				57.8	%
Imaging systems			—				—	%			552				5.3	%
Consumables and other			1,472				30.8	%			2,112				20.5	%
Services			1,260				26.3	%			1,695				16.4	%
License fees and royalties			—				—	%			3				—	%
Total revenue		$	4,783				100.0	%		$	10,326				100.0	%